Dr. Katherine Ransohoff, MD

Dr. Ransohoff practices at Surgery Center Palo Alto in Palo Alto, California.

Dr. Ransohoff's NPI, 1972964880, was assigned on March 19, 2016. Dr. Ransohoff graduated from Stanford University School Of Medicine in 2015. Dr. Ransohoff holds California license A150430.

Dr. Ransohoff's primary practice is Surgery Center Palo Alto, at 795 El Camino Real, Palo Alto, CA 94301. The practice phone is (650) 324-1832.

Dr. Ransohoff's primary practice is Surgery Center Palo Alto in Palo Alto, California. The medical group on file is Palo Alto Foundation Medical Group. Dmand AI also links Dr. Ransohoff to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ransohoff practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Ransohoff's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Ransohoff is board certified in dermatology by the American Board of Dermatology. Dr. Ransohoff is licensed in California.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, contact dermatitis, corns and calluses, hives, itchy rashes and minor head injury among the conditions Dr. Ransohoff treats.

CMS data shows 947 Medicare services from Dr. Ransohoff across 8 procedure codes in 2024, for 304 Medicare patients. Medicare paid $51,540 for them. Every service was in an office.

CMS counts 304 Medicare patients who saw Dr. Ransohoff in 2024. The largest group is 75 to 84, with 128 patients. 67% of them have high cholesterol, and 53% have high blood pressure. Their average risk score is 0.80, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ransohoff's median patient age at 57, with 69% women.

In 2024, Dr. Ransohoff wrote 371 Medicare Part D claims for 161 patients. 92% of them were for generic drugs. CMS names the drug for 241 of them, across 12 drugs with 11 or more claims each, at $43,651 in total drug cost. In 2023, CMS named 551 claims across 19 drugs.

Dr. Ransohoff accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ransohoff as offering telehealth. CMS counts 635 procedures of removal of skin lesions by Dr. Ransohoff, more than 89% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 34 papers to Dr. Ransohoff, published from 2009 to 2023. 2016 was the busiest year, with 6. The most frequent topics are Skin Neoplasms, Carcinoma, Basal Cell and Genetic Predisposition to Disease. Dr. Ransohoff has published most often in J Am Acad Dermatol. Dr. Ransohoff's most frequent co-authors are Kavita Yang Sarin, MD, Joseph Ching-Ming Wu, MD and Harvind S. Chahal, MD.

CMS Open Payments shows 51 general payments to Dr. Ransohoff from 13 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 85% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $328.

Dr. Ransohoff graduated from Stanford University School Of Medicine in 2015.

Dr. Ransohoff is in network with 11 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.